Skip to content

Efficacy OF GATT surgery in Open Angle Glaucoma

Efficacy of Gonioscopy-Assisted Transluminal Trabeculotomy in Open Angle Galucoma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094844
Enrollment
23
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H40- Glaucoma Health Condition 2: H401- Open-angle glaucoma

Interventions

Intervention1: Gonioscopy-Assisted Transluminal Trabeculotomy or GATT: For the GATT procedure, a 5-0 Prolene suture will be thermally blunted using a lowtemperature cautery. The blunted 5-0 prolene s

Sponsors

Maulana Azad medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Moderate to advanced open angle glaucoma. Pseudoexfoliation andpigmentary glaucoma (moderate to severe). Patients with visually significant cataract requiring cataract surgery whose visual acuity is less then or equal to 6/12. Pseudophakic patients with more than 3 months history of cataract surgery.

Exclusion criteria

Exclusion criteria: 1.Mono-ocular patients or one eyed patients. 2. Patient with history of ocular trauma or previous ocular surgery, other than cataract surgery. 3. Patience on anticoagulants. 4. Patients who have corneal pathology or previous corneal refractive Surgery, which will affect the visualisation of angle on gonioscopy and IOP measurement.

Design outcomes

Primary

MeasureTime frame
Number of eyes with complete success of GATT in OAG [defined as IOP less then 18 mmHg or 20% reduction without anti-glaucoma medication (AGM)]Timepoint: 3 Months, 4Months

Secondary

MeasureTime frame
To evaluate the Number of eyes with qualified success of GATT in OAG (defined as IOP less than 18 mmHg or 20% reduction with use of AGM) at 3 months and 4 months. Mean IOP change/reduction post operatively at 3 months and 4 months. Mean change/reduction in the number of anti-glaucoma medications at 3 months and 4 months.Timepoint: 3 months and 4 months

Countries

India

Contacts

Public ContactDr Annu Joon

Maulana Azad medical College

drannujoon@gmail.com7011255026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026